drugset / Trial / NCT06671470
A Drug-drug Interaction Study of YZJ-1139 Tablets and Ticagrelor Tablets in Healthy Subjects
NaSequentialOpen-labelTreatment
Summary
Primary Objective : To evaluate the effect of ticagrelor tablets on the pharmacokinetic characteristics of YZJ-1139 in healthy subjects; Secondary Objective: To evaluate the safety of ticagrelor tablets in combination with YZJ-1139 tablets in healthy subjects.
Timeline
- Start
- 2024-08-22
- Primary completion
- 2024-09-13
- Completion
- 2024-10-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FAZAMOREXANT | Small molecule | 20 mg | Oral |
| Subject | Ticagrelor | Small molecule | 90 mg | Oral |